Literature DB >> 18476457

Aortic stiffness and valvular calcifications in patients with end-stage renal disease.

Tomasz Zapolski1, Andrzej Wysokiński, Lucyna Janicka, Agnieszka Grzebalska, Andrzej Ksiazek.   

Abstract

OBJECTIVES: To evaluate the presence and extent of cardiac calcifications and aortic stiffness in patients with end-stage renal disease (ESRD). PATIENTS AND METHODS: The study group consisted of 60 patients with ESRD with a mean age of 51.7 years, treated with peritoneal dialysis. In all patients transthoracic echocardiogram was performed to assess the following parameters: left ventricular end-systolic diameter, left ventricular end-diastolic diameter (LVEDd), interventricular septum end-diastolic diameter (IVSDd), posterior wall end-diastolic diameter (PWDd), ejection fraction (EF), fractional shortening (FS), aortic maximal and minimal diameter, aortic valve area, mitral valve area (MVA), left ventricular ejection time (LVET), maximal aortic velocity. Aortic stiffness index (AS) was calculated. Aortic and mitral valve calcifications were assessed.
RESULTS: Patients with ESRD had a larger left ventricle (LVEDd 5.4 cm vs. 4.76 cm) and its wall was thicker (IVSDd 1.36 cm vs. 1.02 cm; PWDd 1.31 cm vs. 0.94 cm). Patients had poorer left ventricle contractility (EF 56.1 vs. 61.6%; FS 28.5 vs. 33.2%). Atherosclerotic plaques, calcified plaques and valvular calcifications were more frequently detected in patients with ESRD. Patients with ESRD had significantly higher values of the AS index: (5.34 vs. 3.24). Among ESRD subjects with the stiffer aorta, atherosclerotic plaques including calcificones and the aortic valve damage were more frequently detected.
CONCLUSIONS: Patients with ESRD are characterized by increased aortic stiffness. Atherosclerotic plaques in the aorta as well as cardiac and large vessels calcifications are more common among patients with ESRD. In patients with ESRD there is a correlation between an increase in aortic stiffness and damage of aortic valvular leaflets as well as calcifications of atherosclerotic plaques in the aorta. The degree of aortic stiffness is not related to impairment of mitral valvular leaflets and extravalvular calcifications. A relationship between aortic stiffness and aortic or aortic valve calcifications suggest a different pathogenesis of aorta calcification as compared to that underlying calcifications of other localizations.

Entities:  

Mesh:

Year:  2008        PMID: 18476457

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  5 in total

1.  Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients.

Authors:  Murat H Sipahioglu; Hamit Kucuk; Aydin Unal; Mehmet G Kaya; Fatih Oguz; Bulent Tokgoz; Oktay Oymak; Cengiz Utas
Journal:  Perit Dial Int       Date:  2011-03-31       Impact factor: 1.756

2.  Markers of increased cardiovascular risk in patients with chronic kidney disease.

Authors:  Anna Gluba-Brzózka; Marta Michalska-Kasiczak; Beata Franczyk-Skóra; Marek Nocuń; Maciej Banach; Jacek Rysz
Journal:  Lipids Health Dis       Date:  2014-08-21       Impact factor: 3.876

3.  The reverse remodeling of the aorta in patients after renal transplantation - the value of aortic stiffness index: prospective echocardiographic study.

Authors:  Tomasz Zapolski; Jacek Furmaga; Andrzej Jaroszyński; Anna Wysocka; Sławomir Rudzki; Andrzej P Wysokiński
Journal:  BMC Nephrol       Date:  2017-01-23       Impact factor: 2.388

4.  Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration.

Authors:  Jian-Qiong Xiong; Xue-Mei Chen; Chun-Ting Liang; Wen Guo; Bai-Li Wu; Xiao-Gang Du
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

5.  Real-time imaging required for optimal echocardiographic assessment of aortic valve calcification.

Authors:  Mohamed Yousry; Anette Rickenlund; Johan Petrini; Tomas Gustavsson; Ulrica Prahl; Jan Liska; Per Eriksson; Anders Franco-Cereceda; Maria J Eriksson; Kenneth Caidahl
Journal:  Clin Physiol Funct Imaging       Date:  2012-07-29       Impact factor: 2.273

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.